
Biotech company Snipr Biome has found a partner to help develop new treatments using CRISPR technology, which targets the human microbiome.
The company has teamed up with renowned US cancer hospital MD Anderson Cancer Center, which is associated with the University of Texas. Snipr Biome will work with a research department at the hospital called PRIME-TR.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app